The approval broadens VEXIM’s potential market.
VEXIM is a medical device company focusing on the minimally invasive treatment of traumatic spinal pathologies.
More Articles on Devices:
New Developments in Knee Technology: ATTUNE® Rotating Platform & Anatomic Patella From DePuy Synthes Joint Reconstruction
Pain Management Devices Market in the U.S. to Reach Nearly $2.7B by 2022
Baxano Surgical Receives FDA 510(k) Clearance for Avance MIS Pedicle Screw System
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
